We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Multiple drug resistance remains an unsolved problem in cancer therapy. A previous study has demonstrated that the chemotherapeutic drug doxorubicin (Dox) induced upregulation of P-glycoprotein in endothelial cells, resulting in a 20‑fold increase in drug resistance and reduced efficiency of doxorubicin treatment in a mouse tumor model. In the present(More)
  • 1